High frequencies of antibody responses to CD4 induced epitopes in HIV infected patients started on HAART during acute infection

Human Antibodies

Volumn 14, Issue 3-4, 2005, Pages 115-121

  Robinson, James E ^a,c   Elliott, Debra Holton ^a   Martin, Effie A ^a   Micken, Kathryne ^a   Rosenberg, Eric S ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Envelope glycoproteins; Epitope; HIV 1; Human monoclonal antibodies

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; EPITOPE; GLYCOPROTEIN GP 120; HUMAN MONOCLONAL ANTIBODY; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL TRANSFORMATION; EPSTEIN BARR VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; PRIORITY JOURNAL; PROTEIN BINDING; VIRION;

EID: 33646723851     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2005-143-408     Document Type: Article

References (30)

1. J.M. Binley, R.W. Sanders, B. Clas, N. Schuelke, A. Master, Y. Guo, F. Kajumo, D.J. Anselma, P.J. Maddon, W.C. Olson and J.P. Moore, A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure, J Virol 74 (2000), 627-643.
2. H. Choe, W. Li, P.L. Wright, N. Vasilieva, M. Venturi, C.C. Huang, C. Grundner, T. Dorfman, M.B. Zwick, L. Wang, E.S. Rosenberg, P.D. Kwong, D.R. Burton, J.E. Robinson, J.G. Sodroski and M. Farzan, Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120, Cell 114 (2003), 161-170.
3. K.S. Cole, M. Alvarez, D.H. Elliott, H. Lam, E. Martin, T. Chau, K. Micken, J.L. Rowles, J.E. Clements, M. Murphey-Corb, R.C. Montelaro and J.E. Robinson, Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain, Virology 290 (2001), 59-73.
4. M.K. Gorny, J.Y. Xu, S. Karwowska, A. Buchbinder and S. Zolla-Pazner, Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120, J Immunol 150 (1993), 635-643.
5. C. Grundner, M. Pancera, J.M. Kang, M. Koch, J. Sodroski and R. Wyatt, Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins, Virology 330 (2004), 233-248.
6. B.F. Haynes, J. Fleming, E.W. St Clair, H. Katinger, G. Stiegler, R. Kunert, J. Robinson, R.M. Scearce, K. Plonk, H.F. Staats, T.L. Ortel, H.X. Liao and S.M. Alam, Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies, Science 308 (2005), 1906-1908.
7. E. Henderson, G. Miller, J. Robinson and L. Heston, Efficiency of transformation of lymphocytes by Epstein-Barr virus, Virology 76 (1977), 152-163.
8. D.D. Ho, J.A. McKeating, X.L. Li, T. Moudgil, E.S. Daar, N.C. Sun and J.E. Robinson, Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody, J Virol 65 (1991), 489-493.
9. C.C. Huang, M. Venturi, S. Majeed, M.J. Moore, S. Phogat, M.Y. Zhang, D.S. Dimitrov, W.A. Hendrickson, J. Robinson, J. Sodroski, R. Wyatt, H. Choe, M. Farzan and P.D. Kwong, Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120, Proc Natl Acad Sci USA 101 (2004), 2706-2711.
10. P.D. Kwong, M.L. Doyle, D.J. Casper, C. Cicala, S.A. Leavitt, S. Majeed, T.D. Steenbeke, M. Venturi, I. Chaiken, M. Fung, H. Katinger, P.W. Parren, J. Robinson, D. Van Ryk, L. Wang, D.R. Burton, E. Freire, R. Wyatt, J. Sodroski, W.A. Hendrickson and J. Arthos, HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites, Nature 420 (2002), 678-682.
11. P.D. Kwong, R. Wyatt, J. Robinson, R.W. Sweet, J. Sodroski and W.A. Hendrickson, Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody, Nature 393 (1998), 648-659.
12. A.F. Labrijn, P. Poignard, A. Raja, M.B. Zwick, K. Delgado, M. Franti, J. Binley, V. Vivona, C. Grundner, C.C. Huang, M. Venturi, C.J. Petropoulos, T. Wrin, D.S. Dimitrov, J. Robinson, P.D. Kwong, R.T. Wyatt, J. Sodroski and D.R. Burton, Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1, J Virol 77 (2003), 10557-10565.
13. D.C. Montefiori, M. Altfeld, P.K. Lee, M. Bilska, J. Zhou, M.N. Johnston, F. Gao, B.D. Walker and E.S. Rosenberg, Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual, J Immunol 170 (2003), 3906-3914.
14. D.C. Montefiori, T.S. Hill, H.T. Vo, B.D. Walker and E.S. Rosenberg, Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection, J Virol 75 (2001), 10200-10207.
15. R. Pantophlet, I.A. Wilson and D.R. Burton, Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12, Protein Eng Des Sel 17 (2004), 749-758.
16. M.R. Posner, T. Hideshima, T. Cannon, M. Mukherjee, K.H. Mayer and R.A. Byrn, An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection, J Immunol 146 (1991), 4325-4332.
17. P. Roben, J.P. Moore, M. Thali, J. Sodroski, C.F. Barbas, 3rd. and D.R. Burton, Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1, J Virol 68 (1994), 4821-4828.
18. J.E. Robinson, D. Holton, S. Pacheco-Morell, J. Liu and H. McMurdo, Identification of conserved and variant epitopes of human immunodeficiency virus type 1 (HIV-1) gp120 by human monoclonal antibodies produced by EBV-transformed cell lines, AIDS Res Hum Retroviruses 6 (1990), 567-579.
19. E.S. Rosenberg, M. Altfeld, S.H. Poon, M.N. Phillips, B.M. Wilkes, R.L. Eldridge, G.K. Robbins, R.T. D'Aquila, P.J. Goulder and B.D. Walker, Immune control of HIV-1 after early treatment of acute infection, Nature 407 (2000), 523-526.
20. E.S. Rosenberg, J.M. Billingsley, A.M. Caliendo, S.L. Boswell, P.E. Sax, S.A. Kalams and B.D. Walker, Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia, Science 278 (1997), 1447-1450.
21. C.F. Scott, Jr., S. Silver, A.T. Profy, S.D. Putney, A. Langlois, K. Weinhold and J.E. Robinson, Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain, Proc Natl Acacl Sci USA 87 (1990), 8597-8601.
22. M. Thali, J.P. Moore, C. Furman, M. Charles, D.D. Ho, J. Robinson and J. Sodroski, Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding, J Virol 67 (1993), 3978-3988.
23. A. Trkola, M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J.P. Moore and H. Katinger, Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1, J Virol 70 (1996), 1100-1108.
24. R. Wyatt, E. Desjardin, U. Olshevsky, C. Nixon, J. Binley, V. Olshevsky and J. Sodroski, Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein, J Virol 71 (1997), 9722-9731.
25. R. Wyatt, P.D. Kwong, E. Desjardins, R.W. Sweet, J. Robinson, W.A. Hendrickson and J.G. Sodroski, The antigenic structure of the HIV gp120 envelope glycoprotein, Nature 393 (1998), 705-711.
26. R. Wyatt, J. Moore, M. Accola, E. Desjardin, J. Robinson and J. Sodroski, Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding, J Virol 69 (1995), 5723-5733.
27. S.H. Xiang, N. Doka, R.K. Choudhary, J. Sodroski and J.E. Robinson, Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies, AIDS Res Hum Retroviruses 18 (2002), 1207-1217.
28. S.H. Xiang, M. Farzan, Z. Si, N. Madani, L. Wang, E. Rosenberg, J. Robinson and J. Sodroski, Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody, J Virol 79 (2005), 6068-6077.
29. S.H. Xiang, L. Wang, M. Abreu, C.C. Huang, P.D. Kwong, E. Rosenberg, J.E. Robinson and J. Sodroski, Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains, Virology 315 (2003), 124-134.
30. M.B. Zwick, A.F. Labrijn, M. Wang, C. Spenlehauer, E.O. Saphire, J.M. Binley, J.P. Moore, G. Stiegler, H. Katinger, D.R. Burton and P.W. Parren, Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41, J Virol 75 (2001), 10892-10905.